A5048229494- Diabetes Treatment and Management
- Blood Pressure and Hypertension Studies
- Dialysis and Renal Disease Management
- Chronic Kidney Disease and Diabetes
- Exercise and Physiological Responses
- Cancer Immunotherapy and Biomarkers
- Renal cell carcinoma treatment
- Diabetes Management and Research
- thermodynamics and calorimetric analyses
- Nutritional Studies and Diet
- Ovarian cancer diagnosis and treatment
- Metabolism, Diabetes, and Cancer
- Diet and metabolism studies
- COVID-19 Clinical Research Studies
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- SARS-CoV-2 and COVID-19 Research
- Cancer Risks and Factors
- Erythropoietin and Anemia Treatment
- Liver Disease Diagnosis and Treatment
- Pancreatic function and diabetes
- Cancer, Lipids, and Metabolism
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
University of Campania "Luigi Vanvitelli"
2016-2025
University of Naples Federico II
2012-2024
Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli
2020-2023
Fondazione IRCCS Istituto Nazionale dei Tumori
2014-2023
Cancer Institute (WIA)
2023
Nanostring Technologies (United States)
2023
Tumori Foundation
2023
Istituti di Ricovero e Cura a Carattere Scientifico
2023
Regione Campania
2009-2021
Statistical Service
2021
<h3>Background</h3> Ambulatory blood pressure (BP) measurement allows a better risk stratification in essential hypertension compared with office measurement, but its prognostic role nondialysis chronic kidney disease has been poorly investigated. <h3>Methods</h3> The of daytime and nighttime systolic BP (SBP) diastolic (DBP) comparison measurements was evaluated 436 consecutive patients disease. Primary end points were time to renal death (end-stage or death) fatal nonfatal cardiovascular...
Multiple modifiable risk factors for late complications in patients with diabetic kidney disease (DKD), including hyperglycemia, hypertension and dyslipidemia, increase the of a poor outcome. DKD is associated very high cardiovascular risk, which requires simultaneous treatment these by implementing an intensified multifactorial approach. However, efficacy intervention on major fatal/non-fatal events (MACEs) has been poorly investigated.
Glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium glucose co-transporter-2 (SGLT-2) inhibitors reduce cardiorenal outcomes. We performed a network meta-analysis to compare the effect on outcomes among GLP-1 RAs, SGLT-2 dipeptidyl peptidase-4 (DPP-4) inhibitors.We searched PUBMED, Embase Cochrane databases for relevant studies published up until 10 December 2021. Cardiovascular renal outcome trials reporting GLP-1RA, DPP-4 in patients with or without type 2 diabetes mellitus were...
Background The aims of this paper are to derive a 10-year coronary risk predictive equation for adult Italian men, and assess its accuracy in comparison with the Framingham Heart Study (FHS) PROCAM study equations.
The objective of the current study was to compare, in a large multicenter study, discriminating accuracy four prognostic models developed predict survival patients undergoing nephrectomy for nonmetastatic renal cell carcinoma (RCC).A total 2404 records from 6 European centers were retrospectively reviewed. For each patient, scores calculated according models: Kattan model, University California at Los Angeles integrated staging system (UISS) Yaycioglu and Cindolo model. Survival curves...
<h3>Background</h3> Dietary glycemic load (GL) and index (GI) in relation to cardiovascular disease have been investigated a few prospective studies with inconsistent results, particularly men. The present EPICOR study the association of GI GL coronary heart (CHD) large heterogeneous cohort Italian men women originally recruited European Prospective Investigation into Cancer Nutrition study. <h3>Methods</h3> We studied 47 749 volunteers (15 171 32 578 women) who completed dietary...